Stock NATCAPSUQ6 NATURAL CAPSULES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Natural Capsules Limited

Equities

NATCAPSUQ6

INE936B01015

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 02:01:38 2024-05-17 EDT 		5-day change 1st Jan Change
320 INR +0.16% Intraday chart for Natural Capsules Limited -0.74% -11.05%
03-19 Natural Capsules Begins Production in First High-Speed HPMC Line MT
02-09 Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 645.1 405.1 204.7 670.3 4,321 2,755
Enterprise Value (EV) 1 637.8 467.7 272 767.7 4,785 3,656
P/E ratio 58.1 x 21.2 x 23.9 x 9.7 x 23.3 x 19.8 x
Yield 0.97% 1.54% 1.83% 0.93% 0.22% 0.25%
Capitalization / Revenue 1.18 x 0.68 x 0.33 x 0.84 x 3.2 x 1.6 x
EV / Revenue 1.16 x 0.78 x 0.44 x 0.97 x 3.54 x 2.12 x
EV / EBITDA 11.8 x 9.55 x 5.69 x 7.13 x 19 x 10.8 x
EV / FCF 18.8 x -8.93 x 32.8 x -11.4 x -10.4 x -3.92 x
FCF Yield 5.31% -11.2% 3.05% -8.78% -9.63% -25.5%
Price to Book 1.19 x 0.73 x 0.37 x 1.08 x 3.91 x 2.95 x
Nbr of stocks (in thousands) 6,233 6,233 6,233 6,233 9,349 7,012
Reference price 2 103.5 65.00 32.85 107.6 462.2 393.0
Announcement Date 18-08-23 19-07-26 20-07-20 21-06-21 22-08-26 23-07-04
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 547.6 597.8 615.5 795.1 1,351 1,724
EBITDA 1 54.25 48.96 47.79 107.7 251.3 337.7
EBIT 1 10.93 16.98 11.85 69.9 201.3 267.8
Operating Margin 2% 2.84% 1.92% 8.79% 14.9% 15.54%
Earnings before Tax (EBT) 1 16.82 20.69 13.71 91.55 193.9 249.9
Net income 1 11.11 19.2 8.575 69.12 139.1 184.5
Net margin 2.03% 3.21% 1.39% 8.69% 10.3% 10.7%
EPS 2 1.780 3.070 1.376 11.09 19.84 19.89
Free Cash Flow 1 33.84 -52.39 8.298 -67.38 -460.7 -933
FCF margin 6.18% -8.76% 1.35% -8.47% -34.11% -54.13%
FCF Conversion (EBITDA) 62.38% - 17.36% - - -
FCF Conversion (Net income) 304.59% - 96.77% - - -
Dividend per Share 2 1.000 1.000 0.6000 1.000 1.000 1.000
Announcement Date 18-08-23 19-07-26 20-07-20 21-06-21 22-08-26 23-07-04
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 62.6 67.3 97.4 464 900
Net Cash position 1 7.33 - - - - -
Leverage (Debt/EBITDA) - 1.279 x 1.408 x 0.904 x 1.845 x 2.666 x
Free Cash Flow 1 33.8 -52.4 8.3 -67.4 -461 -933
ROE (net income / shareholders' equity) 2.05% 3.5% 1.54% 11.7% 19.2% 16%
ROA (Net income/ Total Assets) 0.96% 1.46% 1% 5.09% 9.63% 7.39%
Assets 1 1,158 1,315 856.2 1,359 1,445 2,496
Book Value Per Share 2 87.20 89.00 89.20 99.60 118.0 133.0
Cash Flow per Share 2 1.180 0.0900 0.5300 0.1600 1.990 1.600
Capex 1 10.5 71.1 53 235 443 1,059
Capex / Sales 1.92% 11.89% 8.61% 29.52% 32.82% 61.43%
Announcement Date 18-08-23 19-07-26 20-07-20 21-06-21 22-08-26 23-07-04
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
NATURAL CAPSULES LIMITED Stock Natural Capsules Limited
-11.05% 35.44M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.77% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.04% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.77% 239B
NOVARTIS AG Stock Novartis AG
+9.13% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-3.97% 209B
AMGEN INC. Stock Amgen Inc.
+9.27% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NATCAPSUQ6 Stock
  4. Financials Natural Capsules Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW